Table 4.

Utility weight estimates.

Utility Weights	Base Case
Before Treatment	0.72
Neoadjuvant Chemotherapy Start	0.67
Neoadjuvant ICS Surgery	0.74
Neoadjuvant Chemotherapy End	0.74
PCS Surgery	0.67
PCS Chemotherapy	0.67
Chemotherapy to G3/G4 event	0.5
No Further Therapy	0.5

The utility weights were taken from previous literature.[19,20] In order to account for uncertainty, 0.05 standard error was used when using these inputs in our probabilistic sensitivity analysis.